COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
19/01/2018
Company announcement - No. 4/2018 Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018 Zealand receives FDA approval of its Investigational [...]
U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma
19/01/2018
Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous [...]
MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference
19/01/2018
ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase” track at the Precision [...]
Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018
19/01/2018
CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018 operating results before [...]
TiGenix: Transparency Information
19/01/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]
Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine Candidate TNX-801 (Live Horsepox Virus from Cell Culture)
19/01/2018
NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, [...]
CorVel Announces Quarterly Earnings Release Webcast
19/01/2018
IRVINE, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL ) quarterly earnings release, CorVel will stream a webcast over the Internet on Tuesday, January 30 th at 11:30 am [...]
Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
19/01/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee Paris, France - January 19, 2018 [...]
Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif
19/01/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif Paris, France - Le 19 janvier [...]
Tyme Announces Positive Efficacy Data for SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium
19/01/2018
40 percent of evaluable patients achieved survival of more than 12 months, 30 percent achieved a complete or partial tumor response All patients improved or maintained quality of life measures and pain scores SAN [...]
ActivX Biosciences’ KiNativ® platform featured in two articles demonstrating the importance of native kinase profiling for characterizing protein degraders
19/01/2018
LA JOLLA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile, peer-reviewed journals [...]
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma Patients
19/01/2018
Two Partial Responses (25%) by RECIST and Three > 50% Reductions of Alpha Fetoprotein in Eight Evaluable Patients (38%) Treated to Date with Combination of TRC105 and Nexavar® Data Presented at ASCO 2018 [...]
Tauriga Sciences Inc. Completes its Purchase of Crypto Currency Groestlcoin
19/01/2018
NEW YORK, NY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
PHM Announces Further Details of Plan of Arrangement
19/01/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
19/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
19/01/2018
AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech’s True Human™ [...]
Albireo to Receive More than $55 Million(1) in Nondilutive Cash Payments
19/01/2018
— Elobixibat approved in Japan for the treatment of chronic constipation — — Albireo innovation leads to world’s first approved ileal bile acid transporter (IBAT) inhibitor — BOSTON, Jan. 19, 2018 (GLOBE NEWSWIRE) -- [...]
Avinger Granted Continued Listing Decision From Nasdaq
19/01/2018
REDWOOD CITY, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company has received [...]
VitalHub Corp. Announces the Acquisition of Clarity Healthcare Solutions
19/01/2018
TORONTO, Jan. 19, 2018 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV:VHI) (the “Company” or “VitalHub”), is pleased to announce that it has acquired Clarity Healthcare Solutions and other selected assets of Clarity Health [...]

Pages